While the role of PPP1R8 has been investigated in LGG (74), where its deficiency has been shown to decrease cell proliferation and the proportion of cells in the G2/M and S phases while increasing the G0/G1 population, its role in GBM, a highly aggressive glioma, remains unexplored. Here, PPP1R8 is linked to central nervous system cancer.